1. Home
  2. GEHC vs EXE Comparison

GEHC vs EXE Comparison

Compare GEHC & EXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GEHC
  • EXE
  • Stock Information
  • Founded
  • GEHC 1892
  • EXE 1989
  • Country
  • GEHC United States
  • EXE United States
  • Employees
  • GEHC N/A
  • EXE N/A
  • Industry
  • GEHC Computer Software: Prepackaged Software
  • EXE
  • Sector
  • GEHC Technology
  • EXE
  • Exchange
  • GEHC Nasdaq
  • EXE NYSE
  • Market Cap
  • GEHC 34.8B
  • EXE 28.3B
  • IPO Year
  • GEHC N/A
  • EXE 1993
  • Fundamental
  • Price
  • GEHC $69.85
  • EXE $101.97
  • Analyst Decision
  • GEHC Strong Buy
  • EXE Strong Buy
  • Analyst Count
  • GEHC 10
  • EXE 17
  • Target Price
  • GEHC $89.10
  • EXE $129.29
  • AVG Volume (30 Days)
  • GEHC 4.1M
  • EXE 3.7M
  • Earning Date
  • GEHC 07-30-2025
  • EXE 07-29-2025
  • Dividend Yield
  • GEHC 0.19%
  • EXE 2.39%
  • EPS Growth
  • GEHC 41.40
  • EXE N/A
  • EPS
  • GEHC 4.88
  • EXE 0.97
  • Revenue
  • GEHC $19,967,000,000.00
  • EXE $8,863,000,000.00
  • Revenue This Year
  • GEHC $5.16
  • EXE $158.91
  • Revenue Next Year
  • GEHC $4.70
  • EXE $17.95
  • P/E Ratio
  • GEHC $14.31
  • EXE $105.00
  • Revenue Growth
  • GEHC 2.31
  • EXE 116.33
  • 52 Week Low
  • GEHC $57.65
  • EXE $69.12
  • 52 Week High
  • GEHC $94.80
  • EXE $123.35
  • Technical
  • Relative Strength Index (RSI)
  • GEHC 34.31
  • EXE N/A
  • Support Level
  • GEHC $70.32
  • EXE N/A
  • Resistance Level
  • GEHC $78.77
  • EXE N/A
  • Average True Range (ATR)
  • GEHC 1.84
  • EXE 0.00
  • MACD
  • GEHC -0.79
  • EXE 0.00
  • Stochastic Oscillator
  • GEHC 7.85
  • EXE 0.00

About GEHC GE HealthCare Technologies Inc.

GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).

About EXE EXPAND ENERGY CORPORATION

Expand Energy Corp independent natural gas producer in the United States. It is fueling a more affordable, reliable and lower-carbon future. The group focused on developing abundant natural gas, oil, and gas liquids to expand energy access.

Share on Social Networks: